Mycoses

Article	Citations
COVID‐19‐associated mucormycosis: An updated systematic review of literature	187
ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries	143
Invasive pulmonary aspergillosis in the COVID‐19 era: An expected new entity	141
The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus COVID‐19 associated mucormycosis	134
Increased incidence of candidemia in a tertiary care hospital with the COVID‐19 pandemic	122
Mucormycosis and COVID‐19: An epidemic within a pandemic in India	120
Mucormycosis in patients with COVID‐19: A cross‐sectional descriptive multicentre study from Iran	103
Incidence and mortality of COVID‐19‐associated pulmonary aspergillosis: A systematic review and meta‐analysis	78
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k)	76
Characteristics of candidemia in COVID‐19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non‐COVID‐19 patients	72
Prevalence of opportunistic invasive aspergillosis in COVID‐19 patients with severe pneumonia	58
Epidemiology and Mycology of Candidaemia in non‐oncological medical intensive care unit patients in a tertiary center in the United States: Overall analysis and comparison between non‐COVID‐19 and COV	53
Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches	52
COVID‐19–associated pulmonary aspergillosis: a prospective single‐center dual case series	47
Axillary Digital Thermometers uplifted a multidrug‐susceptible Candidaauris outbreak among COVID‐19 patients in Brazil	45
Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals	42
Accuracy of galactomannan testing on tracheal aspirates in COVID‐19‐associated pulmonary aspergillosis	42
Invasive dermatophyte infection: A systematic review	41
Increased incidence of rhino‐orbital mucormycosis in an educational therapeutic hospital during the COVID‐19 pandemic in western Iran: An observational study	39
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases	39
Global prevalence and subgroup analyses of coronavirus disease (COVID‐19) associated Candida auris infections (CACa): A systematic review and meta‐analysis	38
Gut mycobiome: The probable determinative role of fungi in IBD patients	35
Epidemiology of invasive fungal disease in haematologic patients	34
Is there an association between zinc and COVID‐19–associated mucormycosis? Results of an experimental and clinical study	34
Proven COVID‐19—associated pulmonary aspergillosis in patients with severe respiratory failure	32

Molecular characterisation of Candida auris isolates from immunocompromised patients in a tertiary‐care hospital in Kuwait reveals a novel mutation in FKS1 conferring reduced susceptibil	31
Prevalence, risk factors, treatment and outcome of multidrug resistance Candida auris infections in Coronavirus disease (COVID‐19) patients: A systematic review	30
Mortality in critically ill patients with coronavirus disease 2019‐associated pulmonary aspergillosis: A systematic review and meta‐analysis	29
Evaluation of DermaGenius® resistance real‐time polymerase chain reaction for rapid detection of terbinafine‐resistant Trichophyton species	29
Talaromyces marneffei infection in non–HIV‐infected patients in mainland China	29
Estimation of the burden of tinea capitis among children in Africa	28
Risk factors for candidaemia: A prospective multi‐centre case‐control study	27
Systematic screening for COVID‐19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate	27
Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis	27
Serum iron indices in COVID‐19‐associated mucormycosis: A case–control study	27
COVID‐19‐associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID‐19 patients	25
Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years	25
Superficial mycoses, a matter of concern: Global and Indian scenario‐an updated analysis	25
Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: A systematic review and meta‐analysis	25
Point mutations in the squalene epoxidase erg1 and sterol 14‐α demethylase erg11 gene of T indotineae isolates indicate that the resistant mutant strains evolved independently	25
Azole resistance in Aspergillus fumigatus. The first 2‐year's Data from the Danish National Surveillance Study, 2018–2020	23
Host immune responses in dermatophytes infection	23
Tinea capitis et barbae caused by Trichophyton tonsurans: A retrospective cohort study of an infection chain after shavings in barber shops	23
South Asian (Clade I) Candida auris meningitis in a paediatric patient in Iran with a review of the literature	22
The influence of CYP2C19 polymorphisms on voriconazole trough concentrations: Systematic review and meta‐analysis	22
Trichosporon asahii superinfections in critically ill COVID‐19 patients overexposed to antimicrobials and corticosteroids	22
In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes	21
Predicting a therapeutic cut‐off serum level of itraconazole in recalcitrant tinea corporis and cruris—A prospective trial	21
Collateral consequences of agricultural fungicides on pathogenic yeasts: A One Health perspective to tackle azole resistance	20
A review of significance of Aspergillus detection in airways of ICU COVID‐19 patients	20
Tinea pedis—An embarrassing problem for health and beauty—A narrative review	19
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)	19
Expert recommendations for prevention and management of Candida auris transmission	19
Disseminated cryptococcosis and anti‐granulocyte‐macrophage colony‐stimulating factor autoantibodies: An underappreciated association	19
Successful control of Candida auris transmission in a German COVID‐19 intensive care unit	19
Inflammasome‐mediated Inflammation by Malassezia in human keratinocytes: A comparative analysis with different strains	18
New weapons to fight a new enemy: A systematic review of drug combinations against the drug‐resistant fungus Candida auris	18
Anti‐fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta‐analysis	18
Glucan rich nutrition does not increase gut translocation of beta‐glucan	18
Clinical features, diagnosis and treatment outcome of fungal endocarditis: A systematic review of reported cases	17
A screening study for COVID‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic	17
Molecular identification and antifungal susceptibility among clinical isolates of dermatophytes in Shiraz, Iran (2017‐2019)	17
Cryptococcosis among hospitalised patients with COVID‐19: A multicentre research network study	17
A multicentric clinical and epidemiological study of chronic and recurrent dermatophytosis in India	17
Role of flexible bronchoscopy in the diagnosis of invasive fungal infections	17
Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two‐centre mixed cohort study	17
Mucormycosis at a tertiary‐care center in Mexico. A 35‐year retrospective study of 214 cases	17
Report of terbinafine resistantTrichophytonspp. in Italy: Clinical presentations, molecular identification, antifungal susceptibility testing and mutations in the squalene epoxidase gene	17
Malignant Transformation and Treatment Recommendations of Chronic Hyperplastic Candidiasis—A Six‐year Retrospective Cohort Study	16
COVID‐19–associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico	16
Invasive aspergillosis due to Aspergillus cryptic species: A prospective multicentre study	16
Proven Aspergillus flavus pulmonary aspergillosis in a COVID‐19 patient: A case report and review of the literature	16
How does temperature trigger biofilm adhesion and growth in Candida albicans and two non‐Candida albicans Candida species?	16
Complementary effect of mechanism of multidrug resistance in Trichophyton mentagrophytes isolated from human dermatophytoses of animal origin	16
Invasive fungal infections in acute and chronic liver impairment: A systematic review	16

Deep learning‐based diagnosis models for onychomycosis in dermoscopy	15
Dysbiosis of skin mycobiome in atopic dermatitis	15
Aspergillus‐PCR in bronchoalveolar lavage ‐ diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients	15
Performance evaluation of fungal DNA PCR amplification from formalin‐fixed paraffin‐embedded tissue for diagnosis: Experience of a tertiary reference laboratory	15
The design and application of an automated microscope developed based on deep learning for fungal detection in dermatology	15
Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)	15
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors	15
Antifungal susceptibility testing of dermatophytes: Development and evaluation of an optimised broth microdilution method	15
Epidemiology, clinical presentation and management of COVID‐19 associated mucormycosis: A single centre experience from Pune, Western India	14
Implementation of rapid diagnostics assays for detection of histoplasmosis and cryptococcosis in central american people living with HIV	14
Alternative treatment of fungal infections: Synergy with non‐antifungal agents	14
Molecular‐based assessment of diversity and population structure of Sporothrix spp. clinical isolates from Espírito Santo‐Brazil	14
Drug repurposing against Candida auris: A systematic review	14
Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: A single‐centre study	14
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis	14
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting	14
Frequency of occurrence, seasonal variation and antifungal susceptibility of opportunistic Mucorales isolated from hospital soils in Iran	13
Incidence and risk factors for COVID‐19 associated candidemia (CAC) in ICU patients	13
Serious fungal disease incidence and prevalence in Indonesia	13
Itraconazole resistance of Trichophyton rubrum mediated by the ABC transporter TruMDR2	13
Epidemiology and outcomes of allergic bronchopulmonary aspergillosis in the elderly	13
Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda	13
Global epidemiological burden of fungal infections in cirrhosis patients: A systematic review with meta‐analysis	13
Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples	13
Identification of Candida auris and related species by multiplex PCR based on unique GPI protein‐encoding genes	13
Treatment of pulmonary mucormycosis with adjunctive nebulized amphotericin B (MUCONAB trial): Results of an open‐label randomized controlled trial	13
Comparative effectiveness of amphotericin B, azoles and echinocandins in the treatment of candidemia and invasive candidiasis: A systematic review and network meta‐analysis	12
Tinea capitis in children: A single‐institution retrospective review from 2011 to 2019	12
Epidemiology of dermatomycoses and onychomycoses in Ireland (2001–2020): A single‐institution review	12
Sensitization to A fumigatus in subjects with non‐cystic fibrosis bronchiectasis	12
Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single‐centre experience in Iran	12
New insights into development and mortality of COVID‐19‐associated pulmonary aspergillosis in a homogenous cohort of 1161 intensive care patients	12
Diagnostic performance of real‐time polymerase chain reaction assay on blood for invasive aspergillosis and mucormycosis	12
Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: A comparison of galactomannan, mannan and β‐1,3‐D‐gucan testing from serum and cerebr	12
Emergence of Candida auris in intensive care units in Algeria	11
Laboratory‐based surveillance of Candida auris in Colombia, 2016–2020	11
Five‐year surveillance study of clinical and environmental Triazole‐ResistantAspergillus fumigatus isolates in Iran	11
Effects of oestrogen on vulvovaginal candidosis	11
COVID‐19‐associated subacute invasive pulmonary aspergillosis	11
Candida auris from colonisation to candidemia: A four‐year study	11
Azole resistance in Aspergillus isolates by different types of patients and correlation with environment ‐ An Italian prospective multicentre study (ARiA study)	11
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole	11
A pseudo‐outbreak of Rhinocladiella similis in a bronchoscopy unit of a tertiary care teaching hospital in London, United Kingdom	11
Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital	11
Time and cost‐efficient identification of Trichophyton indotineae	11
Direct examination, histopathology and fungal culture for the diagnosis of onychomycosis: A retrospective, comparative study on 2245 specimens	10
Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature	10
Genotyping and antifungal susceptibility testing of Sporothrix brasiliensis isolates from Southern Brazil	10
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes	10
COVID‐19‐associated aspergillosis in a Brazilian referral centre: Diagnosis, risk factors and outcomes	10
Concurrent diagnosis of sinus fungus ball and invasive fungal sinusitis: A retrospective case series	10
Serious fungal diseases in Democratic Republic of Congo – Incidence and prevalence estimates	10
COVID‐19‐associated pulmonary aspergillosis in ICU patients in a German reference centre: Phenotypic and molecular characterisation of Aspergillus fumigatus isolates	10
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non‐fumigatus): A multicentre, non‐interventional regist	10
Genetic differences between Japan and other countries in cyp51A polymorphisms of Aspergillus fumigatus	10
Could cattle dung burning have contributed to the epidemic of COVID‐19‐associated mucormycosis in India? Results of an experimental aero‐mycological study	10
Whole genome sequencing analysis demonstrates therapy‐induced echinocandin resistance in Candida auris isolates	10
Diagnostic accuracy of Aspergillus‐specific antibodies for chronic pulmonary aspergillosis: A systematic review and meta‐analysis	10
Non‐dermatophyte fungi in onychomycosis—Epidemiology and consequences for clinical practice	10
Risk factors of severe blastomycosis and comparison of diagnosis and outcomes between immunocompetent and immunocompromised patients	9
Immune reconstitution inflammatory syndrome in non‐HIV cryptococcal meningitis: Cross‐talk between pathogen and host	9
Changing face of epidemiology of dermatophytoses in Chinese Mainland: A 30 years nationwide retrospective study from 1991 to 2020	9
A lateral flow assay for the immunodiagnosis of human cat‐transmitted sporotrichosis	9
Clinical features and Outcomes of Cryptococcemia patients with and without HIV infection	9
Increasing Incidence of mucormycosis in Spanish inpatients from 1997 to 2018	9
Endemic mycoses: Expansion of traditional geographic ranges and pitfalls in management	9
Comparative diagnostic accuracy of immunoprecipitation versus immunoassay methods for detecting Aspergillus fumigatus‐specific IgG in allergic bronchopulmonary aspergillosis: A syste	9
Clinical and epidemiological characteristics of tinea capitis in northern Taiwan during 2014‐2019: An unusual bimodal distribution of patients and comparison of paediatric and adult cases	9
Real‐life applicability of the Euroarray dermatomycosis kit in the diagnosis of onychomycosis	9
Identification of distinct immunophenotypes in chronic pulmonary aspergillosis using cluster analysis	9
Treatment of onychomycosis in an era of antifungal resistance: Role for antifungal stewardship and topical antifungal agents	8
The accuracy and clinical impact of the morphological identification of Aspergillus species in the age of cryptic species: A single‐centre study	8
Isavuconazole nonwildtype Aspergillus fumigatus isolates from a global surveillance study display alterations in multiple genes involved in the ergosterol biosynthesis pathway not previously as	8
Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic	8
The use of combined PCR, fluorescence in situ hybridisation and immunohistochemical staining to diagnose mucormycosis from formalin‐fixed paraffin‐embedded tissues	8
Aspergillus endocarditis in the recent years, report of cases of a multicentric national cohort and literature review	8
Dihydroorotate dehydrogenase inhibitor olorofim has potent in vitro activity against Microascus/Scopulariopsis, Rasamsonia, Penicillium and Talaromyces species	8
Incidence, predisposing conditions and outcomes of cutaneous mucormycosis: A national database study	8
Antifungal activity of boric acid, triclosan and zinc oxide against different clinically relevant Candida species	8
Multilocus sequence typing (MLST) analysis reveals many novel genotypes and a high level of genetic diversity in Candida tropicalis isolates from Italy and Africa	8

Systematic review of neuroparacoccidioidomycosis: The contribution of neuroimaging	8
Molecular and MALDI‐ToF MS differentiation and antifungal susceptibility of prevalent clinical Fusarium species in China	8
Epidemiological cut‐off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma	8
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence	8
CATastrophe: Response to the challenges of zoonotic sporotrichosis in southern Brazil	8
Activities of nine antifungal agents against Candida auris biofilms	8
Diagnosis of allergic bronchopulmonary aspergillosis in patients with persistent allergic asthma using three different diagnostic algorithms	8
Multilocus sequence typing of strains from the Cryptococcus gattii species complex from different continents	7
Effect of glucocorticoids on the development of COVID‐19‐associated pulmonary aspergillosis: A meta‐analysis of 21 studies and 5174 patients	7
As the virus sowed, the fungus reaped! A comparative analysis of the clinico‐epidemiological characteristics of rhino‐orbital mucormycosis before and during COVID‐19 pandemic	7
Paediatric cutaneous mucormycosis: A case report and review of the literature	7
Vaginal microbiota in pregnant women with inflammatory rheumatic and inflammatory bowel disease: A matched case‐control study	7
Comparative genomics of opportunistic Phialophora species involved in divergent disease types	7
Multicentre derivation and validation of a prognostic scoring system for mortality assessment in HIV‐infected patients with talaromycosis	7
Treatment of the Candida subspecies Candida albicans and Candida parapsilosis with two far‐UVC sources to minimise mycoses in clinical practice	7
Quality of life in women with chronic recurrent vulvovaginal candidosis: A sub‐analysis of the prospective multicentre phase IIb/III Prof‐001 study	7
Characterisation of the nail microbiome in psoriatic and nonpsoriatic patients with onychomycosis	7
Clinical experience with isavuconazole in healthy volunteers and patients with invasive aspergillosis in China, and the results from an exposure–response analysis	7
In vitro antifungal susceptibility patterns of Trichophytonbenhamiae complex isolates from diverse origin	7
The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation	7
Candida spp. infective endocarditis: Characteristics and outcomes of twenty patients with a focus on injection drug use as a predisposing risk factor	7
Fungaemia due to rare yeasts in paediatric intensive care units: A prospective study	7
Risk factors and outcomes of deep tissue Candida invasion in neonates with invasive candidiasis	7
Machine‐learning‐based virtual screening to repurpose drugs for treatment of Candida albicans infection	7
Changing demographics and risk factors for cryptococcosis: A 12‐year review at a tertiary care centre	7
Evaluation of metagenomic next‐generation sequencing diagnosis for invasive pulmonary aspergillosis in immunocompromised and immunocompetent patients	7
Deep convolutional neural networks for onychomycosis detection using microscopic images with KOH examination	7
Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador	6
The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database	6
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study	6
In Vitro activity of ravuconazole against Candida auris and vaginal candida isolates	6
Onychomycosis associated with diabetic foot syndrome: A systematic review	6
A retrospective validation of different scores of guideline adherence and infectious diseases consultation on candidaemia: The higher, the better	6
Prevalence of Candida species in Psoriasis	6
MALDI‐TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples	6
Immunological response and clinical profile in patients with recurrent dermatophytosis	6
Voriconazole is superior to combined itraconazole/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis	6
Surgical management of chronic pulmonary aspergillosis in Africa: A systematic review of 891 cases	6
Prevalence of chronic pulmonary aspergillosis regarding time of tuberculosis diagnosis in Brazil	6
Comparison of four diagnostic criteria for invasive pulmonary aspergillosis—A diagnostic accuracy study in critically ill patients	6
Candidaemia in Central Slovenia: A 12‐year retrospective survey	6
A multicentre, randomised, parallel‐group, double‐blind, vehicle‐controlled and open‐label, active‐controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail	6
EQUAL Fusariosis score 2021: An European Confederation of Medical Mycology score derived from current guidelines to measure QUALity of the clinical management of invasive fusariosis	6
UK standards for microbiology investigations of ear infection (SMI B1) are inadequate for the recovery of fungal pathogens and laboratory diagnosis of otomycosis: A real‐life prospective evaluation	6
Characteristics of late recurrent candidemia in adult patients	6
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training	6
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil	6
Clinical evaluation of two different (1,3)‐ß‐d‐glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study	6
Disinfection trials with terbinafine‐susceptible and terbinafine‐resistant dermatophytes	6
Coexistence of onychomycosis and nail psoriasis and its correlation with systemic treatment	6
Comparing the performance of the common used eumycetoma diagnostic tests	6
Clinical, radiological and laboratory characteristics of central nervous system histoplasmosis: A systematic review of a severe disease	6
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Pr	5
The Austrian landscape of diagnostic capacity and access to treatment for invasive fungal infections	5
Fungal infections in Algeria	5
Increasing incidence of Trichophyton tonsurans in Munich—A single‐centre observation	5
Nikkomycin Z for the treatment of experimental sporotrichosis caused bySporothrix brasiliensis	5
Antifungal use via outpatient parenteral antimicrobial therapy	5
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis	5
Otomycosis: The foremost aetiological agent causing otitis externa and the antifungal susceptibility pattern in North‐Western Iran	5
Dermatophytic melanonychia: A case series of an increasing disease	5
Effectiveness of FastFung agar in the isolation of Malassezia furfur from skin samples	5
A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections	5
Race reporting and representation in onychomycosis clinical trials: A systematic review	5
Molecular epidemiology and clinical‐laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil	5
Altered skin fungal and bacterial community compositions in tinea capitis	5
Compulsory notification of paracoccidioidomycosis: A 14‐year retrospective study of the disease in the state of Paraná, Brazil	5
Matrix‐assisted laser desorption/ionisation‐time of flight mass spectrometry: Protocol standardisation, comparison and database expansion for faster and reliable identification of dermatophytes	5
Using a Madurella mycetomatis‐specific PCR on grains obtained via non‐invasive fine‐needle aspirated material is more accurate than cytology	5
Detection of ERG11 Overexpression in Candida albicans isolates from environmental sources and clinical isolates treated with inhibitory and subinhibitory concentrations of fluconazole	5
Terbinafine resistance in Trichophyton mentagrophytes and Trichophyton rubrum in the Czech Republic: A prospective multicentric study	5
Active screening of COVID‐19‐associated pulmonary aspergillosis with serum beta‐glucan and endotracheal aspirates galactomannan and fungal culture	5
Global prevalence of onychomycosis in general and special populations: An updated perspective	5
Perturbations of immune landscape in COVID‐19 associated mucormycosis	5
Retrospective analysis of onychomycosis prescribing patterns using the medicare part D prescribers database 2016–2020	5
Comparison of risk factors and outcome of patients with and without COVID‐19‐associated pulmonary aspergillosis from Pakistan: A case–control study	5
Interaction between flucloxacillin and azoles: Is isavuconazole next?	5
Development and validation of COVID‐19 associated candidemia score (CAC‐Score) in ICU patients	5
Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases	5
Kerion Celsi in infants and children—A narrative review 2010–2023	5
An open‐label non‐inferiority randomised control trial comparing nebulised amphotericin B with oral itraconazole in patients with pulmonary aspergilloma	5
Comprehensive genome and transcriptome analysis of the dermatophyte Trichophyton schoenleinii reveals the candidate pathogenic genes	5
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospit	5
Performance of the RealStar®Pneumocystis jirovecii PCR kit for the diagnosis of Pneumocystis pneumonia	5
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope	5
A longitudinal study on fluconazole resistance in Candida albicans vaginal isolates	5
Epidemiological analysis of nail aspergillosis and non‐dermatophyte moulds. Criteria for the involvement of Aspergillus in 102 cases of onychomycosis at Montpellier University Hospital, France	5
Evaluation of activity and toxicity of combining clioquinol with ciclopirox and terbinafine in alternative models of dermatophytosis	5
EQUAL Candida score, an effective tool for predicting the outcomes of Candida tropicalis candidaemia: A retrospective cohort study	5
Evaluation of the Post‐Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata	5
Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA‐FLU study	5
Selection and validation of reference genes for qPCR in the human dermatophyte Trichophyton rubrum exposed to different carbon sources which promote adhesion‐inducing conditions	5
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia	4
Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients	4
Therapeutic efficacy of topically used luliconazole vs. terbinafine 1% creams	4